查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625479

自体免疫疾病诊断市场规模、占有率、趋势、行业分析报告（按产品类型、检测类型、最终用户和地区）- 市场预测，2025-2034 年

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2034年全球自体免疫疾病诊断市场规模预计将达到71.4632亿美元。该研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

自体免疫疾病诊断市场是医疗保健和诊断产业的一个分支。市场专注于透过先进的诊断工具和技术来识别和管理自体免疫疾病。当免疫系统攻击身体自体组织时，就会发生自体免疫疾病，导致各种慢性、亚临床症状。这个市场涵盖用于检测这些情况的诊断测试和技术，包括血液检查、影像技术和分子检测。

全球自体免疫疾病的盛行率不断上升，推动了对早期和准确诊断工具的需求。随着对这些疾病的认识不断提高，患者和医疗保健提供者越来越要求更准确、更有效的诊断解决方案。此外，个人化医疗和先进治疗方法的日益普及需要准确的诊断，从而进一步推动市场成长。政府对自体免疫疾病和诊断研究的措施和资金正在促进新诊断方法的开发，从而增加市场机会。

2021年，加速药物伙伴关係（AMP）计画推出了AMP AIM（加速药物伙伴关係自体免疫和免疫介导疾病）计画。 AMP 自体免疫和免疫介导疾病 (AMP AIM) 计划透过提高人们对自体免疫疾病的认识和鼓励早期筛检来推动市场发展。

自体免疫疾病诊断市场正在快速转向先进的自动化诊断解决方案，以提供更高的准确性和更快的结果。人工智慧（AI）和机器学习（ML）融入诊断平台正在改变自体免疫疾病的检测和监测方式，提高效率和准确性。此外，人们越来越关注开发比传统方法更适合患者的非侵入性诊断技术。

2022年7月，KSL Beutner Laboratories（Beutner）宣布在美国推出其间接免疫萤光（IIF）血清血液检测。此检测可有效检测层黏连蛋白 332，一种与持续性自体免疫疾病黏膜类天疱疮 (MMP) 相关的抗原。诊断方法的这些发展正在推动自体免疫疾病诊断市场的成长。

自体免疫疾病诊断市场报告重点

按类型划分，系统性自体免疫疾病诊断部门占据了自体免疫疾病诊断市场收入占有率的主导地位，这主要是由于医疗保健提供者和患者的认识不断提高。

根据测试类型，由于自体免疫疾病的盛行率不断增加和诊断技术的进步，抗核抗体 (ANA) 测试部分预计在预测期内将实现最高复合年增长率。

北美凭藉先进的医疗保健基础设施和大量的医疗研发资金占据市场主导地位。

由于中国和印度等国家医疗保健产业的成长以及自体免疫疾病的盛行率不断上升，预计亚太地区将在预测期内实现最高的复合年增长率。

全球市场的主要参与者有Abbott、AESKU.DIAGNOSTICS、Beckman Coulter、BIOMERIEUX、Bio-Rad Laboratories、EUROIMMUN、F. Hoffmann-La Roche Ltd、Inova Diagnostics（Werfen Group）、Myriad Genetics、Quest Diagnostics、Scipher Medicine、Siemens Healthcare Private Limited、Thermo Fisher Scientific Inc.。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章。
  • 类型快照 自体免疫疾病诊断市场动态
    • 推动因素和机遇
      • 加强意识和筛检计划
      • 增加对医疗保健支出和研究的投资
  • 阻碍因素和课题
      • 需要很长时间才能得到结果，并且需要进行多次诊断测试
  • PESTEL 分析
  • 自体免疫疾病诊断市场类型趋势
  • 价值链分析
  • COVID-19 影响分析

5. 全球自体免疫疾病诊断市场（按产品划分）

  • 主要发现
  • 简介
  • 耗材和检测试剂盒
  • 设备

6. 全球自体免疫疾病诊断市场（按类型）

  • 主要发现
  • 简介
  • 系统性自体免疫疾病的诊断
  • 局部自体免疫疾病的诊断

7. 全球自体免疫疾病诊断市场（按测试类型）

  • 主要发现
  • 简介
  • 抗核抗体（ANA）检测
  • 自体抗体检测 全血球计数 (CBC)
  • 综合代谢面板
  • C反应蛋白（CRP）
  • 其他

8. 全球自体免疫疾病诊断市场（依最终用户划分）

  • 主要发现
  • 简介
  • 医院
  • 诊断中心
  • 实验室

9. 全球自体免疫疾病诊断市场（按地区）

  • 主要发现
  • 简介
      2020 年至 2034 年自体免疫疾病诊断市场区域评估
  • 北美洲
    • 2020 年至 2034 年，北美各产品类别
    • 2020 年至 2034 年，北美按类型划分 北美，依测试类型，2020 年至 2034 年
    • 北美，依最终使用者划分，2020 年至 2034 年
    • 美国
    • 加拿大
  • 欧洲
      欧洲，依产品分类，2020-2034 年 欧洲，依类型，2020 年至 2034 年 2020 年至 2034 年欧洲依测试类型划分 2020 年至 2034 年欧洲终端用户状况
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
      亚太地区：依产品分类，2020 年至 2034 年 2020 年至 2034 年亚太地区各类产品 亚太地区，依测试类型，2020 年至 2034 年 亚太地区：依最终使用者分类，2020 年至 2034 年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
      中东和非洲：依产品分类，2020 年至 2034 年 2020 年至 2034 年中东和非洲各类型 中东和非洲：按测试类型，2020 年至 2034 年
    • 中东和非洲：按最终用户划分，2020 年至 2034 年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲，依产品划分，2020 年至 2034 年
    • 2020 年至 2034 年拉丁美洲各类型
    • 拉丁美洲，依测试类型，2020 年至 2034 年
    • 2020 年至 2034 年拉丁美洲最终用户分布
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第 10 章 竞争格局

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协定/揭露

第 11 章 公司简介

  • Abbott
  • AESKU.DIAGNOSTICS
  • Beckman Coulter, Inc.
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • EUROIMMUN
  • F. Hoffmann-La Roche Ltd
  • Inova Diagnostics（Werfen Group）
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Scipher Medicine
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
Product Code: PM1299

The global autoimmune disease diagnostics market size is expected to reach USD 7,146.32 million by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The autoimmune disease diagnostics market is a sector within the healthcare and diagnostic industry. The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.

The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.

In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.

The autoimmune disease diagnostics market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.

In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the autoimmune disease diagnostics market growth.

Autoimmune Disease Diagnostics Market Report Highlights

Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.

The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.

A few global key market players are Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

  • Consumables and Assay Kits
  • Instruments

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Systemic Autoimmune Disease Diagnostics
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus (SLE)
  • Others
  • Localized Autoimmune Disease Diagnostics
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Hashimoto's Thyroiditis
  • Idiopathic Thrombocytopenic Purpura
  • Others

By Test Type Outlook (Revenue - USD Million, 2020-2034)

  • Antinuclear Antibody (ANA) Tests
  • Autoantibody Tests
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-Reactive Protein (CRP)
  • Others

By End User Outlook (Revenue - USD Million, 2020-2034)

  • Hospitals
  • Diagnostics Centers
  • Research Laboratories

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Autoimmune Disease Diagnostics Market Insights

  • 4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
  • 4.2. Autoimmune Disease Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Awareness and Screening Programs
      • 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
  • 4.3. Restraints and Challenges
      • 4.3.1.1. Prolonged Turnaround Time for Results and Requirement for Multiple Diagnostic Tests
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers (Moderate)
    • 4.4.2. Threats of New Entrants (Low)
    • 4.4.3. Bargaining Power of Buyers (Moderate)
    • 4.4.4. Threat of Substitute (Moderate)
    • 4.4.5. Rivalry Among Existing Firms (High)
  • 4.5. PESTEL Analysis
  • 4.6. Autoimmune Disease Diagnostics Market Type Trends
  • 4.7. Value Chain Analysis
  • 4.8. COVID-19 Impact Analysis

5. Global Autoimmune Disease Diagnostics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • 5.3. Consumables and Assay Kits
    • 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2020-2034 (USD million)
  • 5.4. Instruments
    • 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2020-2034 (USD million)

6. Global Autoimmune Disease Diagnostics Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • 6.3. Systemic Autoimmune Disease Diagnostics
    • 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
    • 6.3.2. Rheumatoid Arthritis
      • 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD million)
    • 6.3.3. Ankylosing Spondylitis
      • 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2020-2034 (USD million)
    • 6.3.4. Systemic Lupus Erythematosus (SLE)
      • 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2020-2034 (USD million)
    • 6.3.5. Others
      • 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
  • 6.4. Localized Autoimmune Disease Diagnostics
    • 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
    • 6.4.2. Multiple Sclerosis
      • 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
    • 6.4.3. Type 1 Diabetes
      • 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2020-2034 (USD million)
    • 6.4.4. Hashimoto's Thyroiditis
      • 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2020-2034 (USD million)
    • 6.4.5. Idiopathic Thrombocytopenic Purpura
      • 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2020-2034 (USD million)
    • 6.4.6. Others
      • 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Autoimmune Disease Diagnostics Market, by Test Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • 7.3. Antinuclear Antibody (ANA) Tests
    • 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2020-2034 (USD million)
  • 7.4. Autoantibody Tests
    • 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2020-2034 (USD million)
  • 7.5. Complete Blood Count (CBC)
    • 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2020-2034 (USD million)
  • 7.6. Comprehensive Metabolic Panel
    • 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2020-2034 (USD million)
  • 7.7. C-Reactive Protein (CRP)
    • 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2020-2034 (USD million)
  • 7.8. Others
    • 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Autoimmune Disease Diagnostics Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 8.3. Hospitals
    • 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 8.4. Diagnostics Centers
    • 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2020-2034 (USD million)
  • 8.5. Research Laboratories
    • 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2020-2034 (USD million)

9. Global Autoimmune Disease Diagnostics Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD million)
  • 9.3. Autoimmune Disease Diagnostics Market - North America
    • 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.3.5. Autoimmune Disease Diagnostics Market - US
      • 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.3.6. Autoimmune Disease Diagnostics Market - Canada
      • 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.4. Autoimmune Disease Diagnostics Market - Europe
    • 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.5. Autoimmune Disease Diagnostics Market - UK
      • 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.6. Autoimmune Disease Diagnostics Market - France
      • 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.7. Autoimmune Disease Diagnostics Market - Germany
      • 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.8. Autoimmune Disease Diagnostics Market - Italy
      • 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.9. Autoimmune Disease Diagnostics Market - Spain
      • 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
      • 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.11. Autoimmune Disease Diagnostics Market - Russia
      • 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
    • 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.5. Autoimmune Disease Diagnostics Market - China
      • 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.6. Autoimmune Disease Diagnostics Market - India
      • 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
      • 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.8. Autoimmune Disease Diagnostics Market - Japan
      • 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
      • 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
      • 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.11. Autoimmune Disease Diagnostics Market - Australia
      • 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.6. Autoimmune Disease Diagnostics Market - UAE
      • 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.7. Autoimmune Disease Diagnostics Market - Israel
      • 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
      • 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • 9.7. Autoimmune Disease Diagnostics Market - Latin America
    • 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
    • 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
    • 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
    • 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
      • 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
      • 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
      • 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
    • 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
      • 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
      • 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
      • 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AESKU.DIAGNOSTICS
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Beckman Coulter, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BIOMERIEUX
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bio-Rad Laboratories, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. EUROIMMUN
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. F. Hoffmann-La Roche Ltd
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Inova Diagnostics (Werfen Group)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Myriad Genetics, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Quest Diagnostics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Scipher Medicine
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Siemens Healthcare Private Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Thermo Fisher Scientific Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development

List of Tables:

  • Table 1 Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 2 Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 3 Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 4 Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 5 North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 6 North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 7 North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 8 North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 9 US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 10 US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 11 US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 12 US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 13 Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 14 Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 15 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 16 Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 17 Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 18 Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 19 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 20 Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 21 UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 22 UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 23 UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 24 UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 25 France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 26 France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 27 France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 28 France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 29 Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 30 Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 31 Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 32 Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 33 Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 34 Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 35 Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 36 Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 37 Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 38 Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 39 Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 40 Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 41 Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 42 Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 43 Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 44 Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 45 Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 46 Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 47 Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 48 Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 49 Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 50 Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 51 Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 52 Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 53 Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 54 Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 55 Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 56 Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 57 China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 58 China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 59 China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 60 China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 61 India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 62 India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 63 India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 64 India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 65 Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 66 Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 67 Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 68 Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 69 Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 70 Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 71 Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 72 Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 73 Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 74 Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 75 Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 76 Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 77 South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 78 South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 79 South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 80 South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 81 Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 82 Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 83 Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 84 Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 85 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 86 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 87 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 88 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 89 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 90 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 91 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 92 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 93 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 94 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 95 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 96 Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 97 UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 98 UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 99 UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 100 UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 101 Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 102 Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 103 Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 104 Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 105 South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 106 South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 107 South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 108 South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 109 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 110 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 111 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 112 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 113 Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 114 Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 115 Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 116 Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 117 Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 118 Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 119 Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 120 Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 121 Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 122 Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 123 Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 124 Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 125 Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 126 Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 127 Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 128 Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • Table 129 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  • Table 130 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  • Table 131 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  • Table 132 Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
  • List of Figures:
  • Figure 1. Global Autoimmune Disease Diagnostics Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Autoimmune Disease Diagnostics Market, by Product, 2024 & 2034 (USD million)
  • Figure 8. Market by Type
  • Figure 9. Global Autoimmune Disease Diagnostics Market, by Type, 2024 & 2034 (USD million)
  • Figure 10. Market by Test Type
  • Figure 11. Global Autoimmune Disease Diagnostics Market, by Test Type, 2024 & 2034 (USD million)
  • Figure 12. Market by End User
  • Figure 13. Global Autoimmune Disease Diagnostics Market, by End User, 2024 & 2034 (USD million)